
With over 200 completed projects and a dedicated team, KCI brings invaluable expertise in preclinical research, ensuring effective drug development strategies tailored to diverse client needs.
Our AAALAC-accredited facilities and GLP-compliant processes maintain the highest quality standards in research practices, guaranteeing reliable and reproducible results for your projects.
We understand that every project is unique. Our flexibility in minimum order quantity (MOQ) allows for tailored solutions, meeting diverse pharmacological research requirements efficiently.
KCI offers a one-stop solution for preclinical studies, from toxicology testing to efficacy assessments, facilitating a streamlined approach to your drug development needs.





Comprehensive preclinical drug development and service platform
Building A2, No, 8 Yanghua road, Suzhou industrial Park, Suzhou.P.R, china